参考文献
[1]CAPOBIANCO I, ROLINGER J, NADALIN S. Resection for Klatskin tumors: Technical complexities and results[J]. Transl Gastroenterol Hepatol, 2018, 3: 69.
[2]BLECHACZ B. Cholangiocarcinoma: Current knowledge and new developments[J]. Gut Liver, 2017, 11(1): 13-26.
[3]NAGINO M, EBATA T, YOKOYAMA Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: A single-center 34-year review of 574 consecutive resections[J]. Ann Surg, 2013, 258(1): 129-140.
[4]KLATSKIN G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features[J]. Am J Med, 1965, 38: 241-256.
[5]CAI XJ. Interpretation of the 8th edition of AJCC Cancer Staging Manual "hilar cholangiocarcinoma"[J]. J Clin Surg, 2018, 26(1): 10-12. (in Chinese)
蔡秀军. 美国癌症联合会(AJCC)癌症分期手册第8版“肝门部胆管癌”部分更新解读[J]. 临床外科杂志, 2018, 26(1): 10-12.
[6]MB A. AJCC cancer staging manual[M]. New York: Springer, 2016.
[7]Study Group of Biliary Tract Surgery in Chinese Society of Surgery of Chinese Medical Association, Hepatobiliary Surgery Professional Committee of PLA. Guidelines for diagnosis and treatment of hilar cholangiocarcinoma (2013) [J]. Chin J Surg, 2013, 51(10): 865-871. (in Chinese)
中华医学会外科学分会胆道外科学组, 解放军全军肝胆外科专业委员会. 肝门部胆管癌诊断和治疗指南(2013版)[J]. 中华外科杂志, 2013, 51(10): 865-871.
[8]EBATA T, KOSUGE T, HIRANO S, et al. Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas[J]. Br J Surg, 2014, 101(2): 79-88.
[9]LI XC, JIANG WJ. Advance in diagnosis and treatment of hilar cholangiocarcinoma[J]. J Abdominal Surg, 2019, 32(1): 7-12. (in Chinese)
李相成, 江王杰. 肝门部胆管癌诊治进展[J]. 腹部外科, 2019, 32(1): 7-12.
[10]BISMUTH H, CORLETTE MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver[J]. Surg Gynecol Obstet, 1975, 140(2): 170-178.
[11]GASPERSZ MP, BUETTNER S, van VUGT J, et al. Evaluation of the New American Joint Committee on cancer staging manual 8th edition for perihilar cholangiocarcinoma[J]. J Gastrointest Surg, 2019. [Epub ahead of print]
[12]SUAREZ-MUNOZ MA, FERNANDEZ-AGUILAR JL, SANCHEZ-PEREZ B, et al. Risk factors and classifications of hilar cholangiocarcinoma[J]. World J Gastrointest Oncol, 2013, 5(7): 132-138.
[13]DEOLIVEIRA ML, SCHULICK RD, NIMURA Y, et al. New staging system and a registry for perihilar cholangiocarcinoma[J]. Hepatology, 2011, 53(4): 1363-1371.
[14]VARGHESE JC, FARRELL MA, COURTNEY G, et al. A prospective comparison of magnetic resonance cholangiopancreatography with endoscopic retrograde cholangiopancreatography in the evaluation of patients with suspected biliary tract disease[J]. Clin Radiol, 1999, 54(8): 513-520.
[15]FARRELL RJ, AGARWAL B, BRANDWEIN SL, et al. Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary strictures[J]. Gastrointest Endosc, 2002, 56(5): 681-687.
[16]JOO I, LEE JM, YOON JH. Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: Recent advances and challenges[J]. Radiology, 2018, 288(1): 7-13.
[17]OLIVEIRA IS, KILCOYNE A, EVERETT JM, et al. Cholangiocarcinoma: Classification, diagnosis, staging, imaging features, and management[J]. Abdom Radiol (NY), 2017, 42(6): 1637-1649.
[18]CHEN HW, PAN AZ, ZHEN ZJ, et al. Preoperative evaluation of resectability of Klatskin tumor with 16-MDCT angiography and cholangiography[J]. AJR Am J Roentgenol, 2006, 186(6): 1580-1586.
[19]LEE HY, KIM SH, LEE JM, et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: Combined CT and cholangiography with revised criteria[J]. Radiology, 2006, 239(1): 113-121.
[20]ALOIA TA, CHARNSANGAVEJ C, FARIA S, et al. High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma[J]. Am J Surg, 2007, 193(6): 702-706.
[21]TILLICH M, MISCHINGER HJ, PREISEGGER KH, et al. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma[J]. AJR Am J Roentgenol, 1998, 171(3): 651-658.
[22]RAZUMILAVA N, GORES GJ. Cholangiocarcinoma[J]. Lancet, 2014, 383(9935): 2168-2179.
[23]PARK MJ, KIM YK, LIM S, et al. Hilar cholangiocarcinoma: Value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation[J]. Radiology, 2014, 270(3): 768-776.
[24]TOUMI N, ABID H, HENCHIR S, et al. Role of magnetic resonance imaging in preoperative assessement of hilar cholangiocarcinoma[J]. Presse Med, 2018, 47(11-12 Pt 1): 950-960.
[25]SOARES KC, KAMEL I, COSGROVE DP, et al. Hilar cholangiocarcinoma: Diagnosis, treatment options, and management[J]. Hepatobiliary Surg Nutr, 2014, 3(1): 18-34.
[26]ROMANEEHSEN B, OTTO G, LOHSE AW, et al. Diagnostic imaging of hilar cholangiocarcinoma: Preoperative evaluation of ERC, MRC and PTC in comparison with histopathology[J]. Rofo, 2004, 176(12): 1750-1758.
[27]WEBER A, von WEYHERN C, FEND F, et al. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma[J]. World J Gastroenterol, 2008, 14(7): 1097-1101.
[28]HIJIOKA S, HARA K, MIZUNO N, et al. A novel technique for endoscopic transpapillary "mapping biopsy specimens" of superficial intraductal spread of bile duct carcinoma (with videos)[J]. Gastrointest Endosc, 2014, 79(6): 1020-1025.
[29]KAWASHIMA H, ITOH A, OHNO E, et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: A retrospective study of efficacy and risk factors related to complications[J]. Ann Surg, 2013, 257(1): 121-127.
[30]SAKUMA Y, KODAMA Y, SOGABE Y, et al. Diagnostic performance of a new endoscopic scraper for malignant biliary strictures: A multicenter prospective study[J]. Gastrointest Endosc, 2017, 85(2): 371-379.
[31]JI GW, ZHU FP, LI XC. Progress in application of three-dimensional imaging technique in complex hepatobiliary surgery[J]. Chin J Surg, 2017, 55(4): 316-320. (in Chinese)
季顾惟, 朱飞鹏, 李相成. 三维影像学技术在复杂肝胆外科手术中的应用进展[J]. 中华外科杂志, 2017, 55(4): 316-320.
[32]WANG Y, YANG H, SHEN C, et al. Surgical procedure and long-term survival of hilar cholangiocarcinoma[J]. Int J Clin Exp Med, 2015, 8(1): 1122-1128.
[33]LIM JH, CHOI GH, CHOI SH, et al. Liver resection for Bismuth type I and Type II hilar cholangiocarcinoma[J]. World J Surg, 2013, 37(4): 829-837.
[34]XIONG J, NUNES QM, HUANG W, et al. Major hepatectomy in Bismuth types I and II hilar cholangiocarcinoma[J]. J Surg Res, 2015, 194(1): 194-201.
[35]HIROSE T, IGAMI T, EBATA T, et al. Surgical and Radiological Studies on the Length of the Hepatic Ducts[J]. World J Surg, 2015, 39(12): 2983-2989.
[36]KUANG D, WANG GP. Hilar cholangiocarcinoma: Pathology and tumor biology[J]. Front Med China, 2010, 4(4): 371-377.
[37]JARNAGIN WR, BOWNE W, KLIMSTRA DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma[J]. Ann Surg, 2005, 241(5): 703-712; discussion 712-714.
[38]de JONG MC, MARQUES H, CLARY BM, et al. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: A multi-institutional analysis of 305 cases[J]. Cancer, 2012, 118(19): 4737-4747.
[39]MATSUYAMA R, MORI R, OTA Y, et al. Significance of vascular resection and reconstruction in surgery for hilar cholangiocarcinoma: With special reference to hepatic arterial resection and reconstruction[J]. Ann Surg Oncol, 2016, 23(Suppl 4): 475-484.
[40]YOUNG AL, IGAMI T, SENDA Y, et al. Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion[J]. HPB (Oxford), 2011, 13(7): 483-493.
[41]NAGINO M, NIMURA Y, NISHIO H, et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: An audit of 50 consecutive cases[J]. Ann Surg, 2010, 252(1): 115-123.
[42]CHEN W, KE K, CHEN YL. Combined portal vein resection in the treatment of hilar cholangiocarcinoma: A systematic review and meta-analysis[J]. Eur J Surg Oncol, 2014, 40(5): 489-495.
[43]HARTOG H, IJZERMANS JN, van GULIK TM, et al. Resection of Perihilar Cholangiocarcinoma[J]. Surg Clin North Am, 2016, 96(2): 247-267.
[44]MAO K, LIU J, SUN J, et al. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma[J]. J Gastroenterol Hepatol, 2016, 31(2): 417-426.
[45]GIULIANTE F, ARDITO F, GUGLIELMI A, et al. Association of lymph node status with survival in patients after Liver resection for hilar cholangiocarcinoma in an Italian multicenter analysis[J]. JAMA Surg, 2016, 151(10): 916-922.
[46]KAMBAKAMBA P, LINECKER M, SLANKAMENAC K, et al. Lymph node dissection in resectable perihilar cholangiocarcinoma: A systematic review[J]. Am J Surg, 2015, 210(4): 694-701.
[47]LI XC, JI GW. Radical resection of hilar cholangiocarcinoma[J]. J Surg Concepts Pract, 2017, 22(3): 185-190. (in Chinese)
李相成, 季顾惟. 肝门部胆管癌的根治性切除[J]. 外科理论与实践, 2017, 22(3): 185-190.
[48]BELGHITI J, HIRAMATSU K, BENOIST S, et al. Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection[J]. J Am Coll Surg, 2000, 191(1): 38-46.
[49]KAWAKAMI H, KUWATANI M, ONODERA M, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma[J]. J Gastroenterol, 2011, 46(2): 242-248.
[50]ZHANG XF, BEAL EW, MERATH K, et al. Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival[J]. J Surg Oncol, 2018, 117(6): 1267-1277.
[51]MAY BJ, MADOFF DC. Controversies of preoperative portal vein embolization[J]. Hepat Oncol, 2016, 3(2): 155-166.
[52]PICHLMAYR R, WEIMANN A, TUSCH G, et al. Indications and role of liver transplantation for malignant tumors[J]. Oncologist, 1997, 2(3): 164-170.
[53]MEYER CG, PENN I, JAMES L. Liver transplantation for cholangiocarcinoma: Results in 207 patients[J]. Transplantation, 2000, 69(8): 1633-1637.
[54]ROBLES R, FIGUERAS J, TURRIN VS, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma[J]. Ann Surg, 2004, 239(2): 265-271.
[55]de VREEDE I, STEERS JL, BURCH PA, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma[J]. Liver Transpl, 2000, 6(3): 309-316.
[56]HEIMBACH JK, GORES GJ, HADDOCK MG, et al. Liver transplantation for unresectable perihilar cholangiocarcinoma[J]. Semin Liver Dis, 2004, 24(2): 201-207.
[57]ROSEN CB, HEIMBACH JK, GORES GJ. Liver transplantation for cholangiocarcinoma[J]. Transpl Int, 2010, 23(7): 692-697.
[58]GORES GJ, DARWISH MURAD S, HEIMBACH JK, et al. Liver transplantation for perihilar cholangiocarcinoma[J]. Dig Dis, 2013, 31(1): 126-129.
[59]MACHAIRAS N, KOSTAKIS ID, TSILIMIGRAS DI, et al. Liver transplantation for hilar cholangiocarcinoma: A systematic review[J]. Transplant Rev (Orlando), 2020, 34(1): 100516.
[60]DARWISH MURAD S, KIM WR, HARNOIS DM, et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers[J]. Gastroenterology, 2012, 143(1): 88-98.e3; quiz e14.
[61]MORIS D, KOSTAKIS ID, MACHAIRAS N, et al. Comparison between liver transplantation and resection for hilar cholangiocarcinoma: A systematic review and meta-analysis[J]. PLoS One, 2019, 14(7): e0220527.